Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?

Robert J. Lukavsky, Rafael A. Couto, William P. Adams

Research output: Contribution to journalReview articlepeer-review

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a complex topic with evolving classification and etiology. Commonalities between BIA-ALCL and lymphoproliferative disorders exist, suggesting that BIA-ALCL may be better represented on a spectrum of disease from benign effusion to malignant metastatic lymphoma. Meticulous sterile surgical technique, involving the use of betadine-containing irrigation, should be used to decrease the biological burden introduced into the surgical field and possibly prevent future incidences of BIA-ALCL.

Original languageEnglish (US)
Pages (from-to)71-77
Number of pages7
JournalClinics in Plastic Surgery
Volume48
Issue number1
DOIs
StatePublished - Jan 2021

Keywords

  • Breast augmentation
  • Breast implant-associated anaplastic large cell lymphoma
  • Lymphoproliferative disorders

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?'. Together they form a unique fingerprint.

Cite this